Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03891784
Title Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Washington
Indications

gastrointestinal neuroendocrine tumor

esophageal neuroendocrine tumor

pancreatic endocrine carcinoma

Therapies

Abemaciclib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.